Vascular surgery

M2S and NAMSA Collaboration to Nest Pre-market Vascular Device Trials in Registries

Retrieved on: 
Wednesday, June 23, 2021
Research, Technology, Medical devices, Surgery, Clinical trials, Cardiology, Software, Health, Data management, Science, Medical specialties, Surgery, Medicine, Kenneth Ouriel, Vascular surgery, Society for Vascular Surgery, M2S/Medstreaming, NAMSA, M2S/MEDSTREAMING, NAMSA

M2S provides national registry services for the Society for Vascular Surgery Vascular Quality Initiative (VQI) which collects extensive data on vascular procedures, including the devices used, in over 800 U.S. hospitals.

Key Points: 
  • M2S provides national registry services for the Society for Vascular Surgery Vascular Quality Initiative (VQI) which collects extensive data on vascular procedures, including the devices used, in over 800 U.S. hospitals.
  • Pre-market device trials require additional functions provided by a CRO, with which NAMSA has extensive experience.
  • Registry-nested trials eliminate duplicate data entry by sites since most data required for such trials are already being collected.
  • Dr. Kenneth Ouriel, NAMSA Chief Medical Officer stated, NAMSA has provided CRO services for many pre-market vascular device trials.

Peripheral Artery Disease Market - Global Opportunity Analysis and Industry Forecast 2020-2030 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, June 22, 2021
Health, Cardiology, Circulatory system, Cardiovascular system, Medical specialties, Interventional radiology, Vascular surgery, Cardiovascular physiology, Peripheral artery disease, Atherectomy, Peripheral vascular system, Artery disease, Artery

The "Peripheral Artery Disease Market by Type, Global Opportunity Analysis and Industry Forecast, 2020 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Peripheral Artery Disease Market by Type, Global Opportunity Analysis and Industry Forecast, 2020 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • At an estimated value of over USD 4.53 billion in 2019, the Global Peripheral Artery Disease Market is predicted to thrive at a CAGR of 6.2% and valued at over USD 8.78 billion over the forecast year 2020-2030.
  • Peripheral artery disease is a common circulatory problem that causes narrowing of the peripheral arteries.
  • Straub Medical AG develops medical atherectomy & thrombectomy devices for the treatment of venous disease and peripheral arterial disease (PAD).

Medical Vein Clinic Announces Expansion of Services to Treat Patients with Lymphatic Disease

Retrieved on: 
Tuesday, June 15, 2021
Medical specialties, Angiology, Circulatory system, Vascular surgery, Varicose veins, Vein, Edema, Vascular diseases, Vein disorders

Dr. Trock will complement the clinic's varicose vein treatment experts, extending their services to care for patients suffering from lymphatic disease.

Key Points: 
  • Dr. Trock will complement the clinic's varicose vein treatment experts, extending their services to care for patients suffering from lymphatic disease.
  • He is dedicated to evaluating and educating patients along with developing home treatment plans to resolve vein pain and swelling associated with vein disease.
  • "Early detection and treatment of vein and lymphatic disease is critical to prevent patients from experiencing a decline in physical functions and becoming debilitated," noted Dr. John Hogg, founder of Medical Vein Clinic.
  • Medical Vein Clinic has treated thousands of patients with vein and lymphatic disease, helping them lead fuller, healthier lives.

LeMaitre to Present at the Goldman Sachs Virtual Global Healthcare Conference

Retrieved on: 
Wednesday, June 9, 2021
LeMaitre Vascular, Lemaitre, Vascular surgery, Lemaitre, Musical groups, Musicians

BURLINGTON, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc.(Nasdaq:LMAT) announced today thatDavid Roberts, President, will present attheGoldman Sachs 42nd Annual Virtual Global Healthcare Conference onThursday, June 10, 2021, at5:30 PM ET.

Key Points: 
  • BURLINGTON, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc.(Nasdaq:LMAT) announced today thatDavid Roberts, President, will present attheGoldman Sachs 42nd Annual Virtual Global Healthcare Conference onThursday, June 10, 2021, at5:30 PM ET.
  • LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide.
  • The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon.
  • Additional information can be found at www.lemaitre.com .

AI triage solution for deadly vascular conditions receives FDA clearance and CE Mark

Retrieved on: 
Wednesday, June 2, 2021
Anatomy, Medical specialties, Circulatory system, Medical emergencies, Vascular surgery, Projectional radiography, Aortic dissection, IgG4-related disease, Pulmonary embolism, Aorta, Dissection, Embolism

Pulmonary embolism is the blockage of an artery in the lungs and is one of the major causes of death, morbidity, and hospitalization worldwide.

Key Points: 
  • Pulmonary embolism is the blockage of an artery in the lungs and is one of the major causes of death, morbidity, and hospitalization worldwide.
  • It is difficult to diagnose PE as it manifests in diverse ways and can be mimicked by a range of other conditions.
  • CINA CHEST provides rapid automatic PE detection on CT chest angiography, providing clinicians with accurate and rapid real-time alerts on the disease.
  • Aortic dissection is a tear in the inner layer of the aorta, allowing blood to flow between the layers.

InspireMD Announces Warrants Exchange Listing Transfer to Nasdaq

Retrieved on: 
Thursday, May 27, 2021
Medical specialties, Angiology, Vascular diseases, Cardiovascular system, Neurosurgery, Vascular surgery, Carotid artery stenosis, Carotid stenting, Stroke, Carotid artery, NASDAQ

TEL AVIV, Israel, May 27, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today announced the Companys warrants, NSPR.WS and NSPR.WSB, currently traded on the NYSE: American, have been approved for listing on The Nasdaq Capital Market (Nasdaq).

Key Points: 
  • TEL AVIV, Israel, May 27, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today announced the Companys warrants, NSPR.WS and NSPR.WSB, currently traded on the NYSE: American, have been approved for listing on The Nasdaq Capital Market (Nasdaq).
  • Trading is expected to begin onJune 8, 2021, under the symbols NSPRW and NSPRZ on the Nasdaq.
  • InspireMD seeks to utilize its proprietary MicroNet technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free, long-term outcomes.
  • Investors and security holders are urged to read these documents free of charge on the SECs web site at http://www.sec.gov.

Rapid Medical Announces Closing of $50m Series D Financing

Retrieved on: 
Tuesday, May 25, 2021
General Health, Health, Medical devices, Revascularization, Vascular surgery, Jefferies Group

Rapid Medical, a company focused on the development of responsive, adjustable neurovascular devices, announced today that it has completed an oversubscribed Series D financing of $50M.

Key Points: 
  • Rapid Medical, a company focused on the development of responsive, adjustable neurovascular devices, announced today that it has completed an oversubscribed Series D financing of $50M.
  • Rapid Medical recently announced the FDA clearance of its TIGERTRIEVER revascularization device for use in the treatment of ischemic stroke.
  • As part of the financing round, Chen Chen, a principle at CPE, will join Rapid Medicals board of directors.
  • Jefferies LLC served as exclusive placement agent for Rapid Medical in the financing.

Upper East Side Cardiology Launches New Vein Institute as Extension to Personalized Patient Services

Retrieved on: 
Monday, May 24, 2021
Angiology, Medical specialties, Cardiovascular system, Veins, Vascular surgery, Varicose veins

NEW YORK, May 24, 2021 /PRNewswire/ --One of New York City's leading cardiac treatment centers, Upper East Side Cardiology , led by Satjit Bhusri, MD, FACC, announced today the launch of The Vein Institute - The Premier Varicose Vein Treatment Center on the Upper East Side.

Key Points: 
  • NEW YORK, May 24, 2021 /PRNewswire/ --One of New York City's leading cardiac treatment centers, Upper East Side Cardiology , led by Satjit Bhusri, MD, FACC, announced today the launch of The Vein Institute - The Premier Varicose Vein Treatment Center on the Upper East Side.
  • That's why The Vein Institute is so dedicated to creating customized treatment plans for our patients to restore both their vascular health and comfort."
  • The Vein Institute at Upper East Side Cardiology offers several, personalized treatment options for varicose veins, most of which are covered by insurance including:
    VenaSeal an advanced technique that quickly and safely eliminates the veins using a specially formulated adhesive.
  • Dr. Bhusri is one of the only physicians on the Upper East Side to utilize this leading technology for the treatment of varicose veins.

Vascular Institute of the Rockies Opens First-Ever Cardiovascular Multidisciplinary Center in Colorado

Retrieved on: 
Friday, May 21, 2021
Medical specialties, Vascular surgery, Interventional radiology, Radiology, Vir, Interventional cardiology, Medicine, Clinical medicine

b'DENVER, May 21, 2021 /PRNewswire-PRWeb/ -- Vascular Institute of the Rockies (VIR), in partnership with Advanced Heart & Vein Center (AHVC), Denver Interventional, Vascular Labs of the Rockies, and Surgical Care Affiliates, is pleased to open the first-of-its-kind building that is:\nThe first-ever cardiovascular multidisciplinary center in Colorado with collaboration between vascular surgery, interventional cardiology and interventional radiology.\nThe first-ever cardiovascular Ambulatory Surgery Center (ASC) in Colorado.\nThe first-ever multi-specialty center in Colorado to function as a hybrid Ambulatory Surgery Center (ASC) and Office Based Laboratory (OBL) which offers the following benefits to patients:\nThis unique building, located at 4105 E. Florida Ave., Denver, CO 80222, offers vascular, cardiac and interventional radiology services in a safe, spacious, state-of-the-art outpatient setting.

Key Points: 
  • b'DENVER, May 21, 2021 /PRNewswire-PRWeb/ -- Vascular Institute of the Rockies (VIR), in partnership with Advanced Heart & Vein Center (AHVC), Denver Interventional, Vascular Labs of the Rockies, and Surgical Care Affiliates, is pleased to open the first-of-its-kind building that is:\nThe first-ever cardiovascular multidisciplinary center in Colorado with collaboration between vascular surgery, interventional cardiology and interventional radiology.\nThe first-ever cardiovascular Ambulatory Surgery Center (ASC) in Colorado.\nThe first-ever multi-specialty center in Colorado to function as a hybrid Ambulatory Surgery Center (ASC) and Office Based Laboratory (OBL) which offers the following benefits to patients:\nThis unique building, located at 4105 E. Florida Ave., Denver, CO 80222, offers vascular, cardiac and interventional radiology services in a safe, spacious, state-of-the-art outpatient setting.
  • VIR also serves the larger Rocky Mountain region with outreach clinics in Steamboat Springs, Vail/Avon, Greeley, Thornton, Alamosa/Del Norte and Colby, KS.
  • VIR providers are specially trained in all vascular conditions, treatment options and surgical procedures including: Abdominal Aortic Aneurysms, Acute DVTs, Carotid Artery Disease, Chronic Venous Disease, Peripheral Arterial Disease, Pelvic Venous Disorders, Thoracic Outlet Syndrome, Varicose/Spider Veins and Vascular Malformations.
  • VIR can be reached at 303-539-0736 or visit us online at http://www.vascularinstitute.com .\nChristy Maraone, Vascular Institute of the Rockies, +1 (720) 320-5724, [email protected]\n'

LeMaitre to Present at the Jefferies Virtual Healthcare Conference

Retrieved on: 
Thursday, May 20, 2021
XC2, LeMaitre Vascular, Vascular surgery, Lemaitre

b'BURLINGTON, Mass., May 20, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc.\xc2\xa0(Nasdaq:LMAT) announced today that\xc2\xa0JJ Pellegrino, Chief Financial Officer, will present at\xc2\xa0the Jefferies Virtual Healthcare Conference\xc2\xa0on\xc2\xa0Friday, June 4, 2021, at\xc2\xa01:30 PM EDT.\nLeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide.

Key Points: 
  • b'BURLINGTON, Mass., May 20, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc.\xc2\xa0(Nasdaq:LMAT) announced today that\xc2\xa0JJ Pellegrino, Chief Financial Officer, will present at\xc2\xa0the Jefferies Virtual Healthcare Conference\xc2\xa0on\xc2\xa0Friday, June 4, 2021, at\xc2\xa01:30 PM EDT.\nLeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide.
  • The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon.
  • Additional information can be found at www.lemaitre.com .\n'